Liz Chatwin

Liz Chatwin holds extensive experience in the pharmaceutical industry, having served in various leadership roles, including Director of Market Access and Strategic Planning at AstraZeneca from May 2006 to August 2008. In this capacity, responsibilities included overseeing sales and profit for Oncology and CNS brands in China, managing a sizable team of 550 sales and marketing professionals, and achieving significant annual turnover of US$250 million with a growth rate of 20%. Liz has also held positions such as VP of Global Sustainability and SHE, Global Franchise Head for Breast Cancer, Country President for Korea, Australia, and New Zealand, and VP of Global Pricing and Market Access at AstraZeneca, focusing on pricing strategies and payer needs. Additionally, prior experience includes a role as Marketing Manager and Business Unit Head for Oncology at Novartis. Liz Chatwin holds a Bachelor of Business in Marketing from the University of Technology, Sydney.